Stem cell exosomes for treating facial melasma
Part of Skin clinical trials.
This trial tests whether stem cell exosomes, combined with laser or microneedle treatments, can improve melasma (dark patches on the face). It aims to find a better way to lighten these spots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have melasma (chloasma) on your face, diagnosed by a doctor.
- You should not have other skin conditions that cause dark patches, like post-inflammatory pigmentation or certain birthmarks.
- You must agree not to use other cosmetic treatments for melasma during the study.
- You cannot be pregnant or breastfeeding.
- You must not have taken oral contraceptives or hormone therapy in the past year.
- You cannot have serious allergies, scar-prone skin, or active skin infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a cream made from stem cell secretions to see if it can help reduce melasma (dark patches on the face). It may be an option for women who haven't improved with other treatments.
This trial tests if adding a special serum to laser treatment can better treat dark spots from acne and melasma in women with medium to dark skin tones. The serum contains ingredients that may help lighten spots and improve skin tone.
This trial tests two injectable treatments for melasma (dark patches on the face): platelet-rich fibrin, which uses your own blood cells to promote healing, and tranexamic acid, a medication that may reduce pigmentation. The study will compare which works better for women with mild to moderate melasma.
This study tests whether combining oral tranexamic acid with a special skin needling treatment helps reduce melasma (dark facial patches). It is designed for women aged 18-50 who have melasma and are not pregnant or on certain medications.
This trial tests a treatment called Secretome TGF Beta 3 for women with melasma. It aims to see if this treatment can improve dark patches on the skin.
This study tests a new gel (SM-030) for adults with moderate to severe melasma. If you join, you would use the gel on your face for a few months and stop other skin-lightening products, while applying the provided sunscreen every day.
Hear when a new Melasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.